Related references
Note: Only part of the references are listed.Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity-Two Villains or One?
Robert A. Roth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
A Mouse Model of Severe Halothane Hepatitis Based on Human Risk Factors
Christine M. Dugan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Regulation of Adaptive Immunity by the Innate Immune System
Akiko Iwasaki et al.
SCIENCE (2010)
TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction
Nithya Mariappan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Effect of PolyI:C Cotreatment on Halothane-Induced Liver Injury in Mice
Linling Cheng et al.
HEPATOLOGY (2009)
Tumor Necrosis Factor alpha Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide Coexposure
Patrick J. Shaw et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in Mice
Patrick J. Shaw et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models
Xiaomin Deng et al.
PHARMACOLOGICAL REVIEWS (2009)
Hepatotoxic Interaction of Sulindac with Lipopolysaccharide: Role of the Hemostatic System
Wei Zou et al.
TOXICOLOGICAL SCIENCES (2009)
Trovafloxacin Enhances TNF-Induced Inflammatory Stress and Cell Death Signaling and Reduces TNF Clearance in a Murine Model of Idiosyncratic Hepatotoxicity
Patrick J. Shaw et al.
TOXICOLOGICAL SCIENCES (2009)
The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability
Patrick J. Shaw et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Biochemical mechanisms in drug-induced liver injury: Certainties and doubts
Ignazio Grattagliano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Dendritic Cell IL-23 and IL-1 Production in Response to Schistosome Eggs Induces Th17 Cells in a Mouse Strain Prone to Severe Immunopathology
Mara G. Shainheit et al.
JOURNAL OF IMMUNOLOGY (2008)
Halothane hepatitis in Iran: A review of 59 cases
Payam Eghtesadi-Araghi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Mechanisms of trovafloxacin hepatotoxicity: Studies of a model cyclopropylamine-containing system
Qin Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Russell A. Wilke et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha
Patrick J. Shaw et al.
TOXICOLOGICAL SCIENCES (2007)
Role of the coagulation system in acetaminophenInduced hepatotoxicity in mice
Patricia E. Ganey et al.
HEPATOLOGY (2007)
IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells
Akihiro Kimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities
Michie M. K. Ong et al.
TOXICOLOGICAL SCIENCES (2007)
Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury
Yi-Shin Huang
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Mitochondrial abnonnalities - A link to idiosyncratic drug hepatotoxicity?
Urs A. Boelsterli et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Modest inflammation enhances diclofenac hepatotoxicity in rats: Role of neutrophils and bacterial translocation
Xiaomin Deng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Reactive intermediates and the pathogenesis of adverse drug reactions: The toxicology perspective
DE Amacher
CURRENT DRUG METABOLISM (2006)
Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction
Jack Uetrecht
DRUG METABOLISM REVIEWS (2006)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
JL Walgren et al.
CRITICAL REVIEWS IN TOXICOLOGY (2005)
Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects
I Sanne et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Idiosyncratic liver injury: Challenges and approaches
PB Watkins
TOXICOLOGIC PATHOLOGY (2005)
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
GP Aithal et al.
HEPATOLOGY (2004)
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice
WT Huang et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor
PE Ganey et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2004)
Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved
K He et al.
DRUG METABOLISM AND DISPOSITION (2004)
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
RJ Andrade et al.
HEPATOLOGY (2004)
Idiosyncratic toxicity: the role of toxicophores and bioactivation
DP Williams et al.
DRUG DISCOVERY TODAY (2003)
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
UA Boelsterli
TOXICOLOGY AND APPLIED PHARMACOLOGY (2003)
Heterogeneity of toxicant response: Sources of human variability
JE Aldridge et al.
TOXICOLOGICAL SCIENCES (2003)
Inflammation and drug idiosyncrasy - Is there a connection?
RA Roth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats
JP Luyendyk et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Screening for the potential of a drug candidate to cause idiosyncratic drug reactions
J Uetrecht
DRUG DISCOVERY TODAY (2003)
Medical progress: Drug-induced hepatotoxicity
WM Lee
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Interferon-γ induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis
Y Watanabe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Troglitazone-induced liver failure: A case study
DJ Graham et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes
S Shishido et al.
HEPATOLOGY (2003)
In vitro studies on the toxicity of isoniazid in different cell lines
CE Schwab et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2003)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
A review of the common properties of drugs with idiosyncratic hepatotoxicity and the multiple determinant hypothesis for the manifestation of idiosyncratic drug toxicity
AP Li
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
Effects of entacapone and tolcapone on mitochondrial membrane potential
K Haasio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Effects of troglitazone on HepG2 viability and mitochondrial function
MA Tirmenstein et al.
TOXICOLOGICAL SCIENCES (2002)
Timing of new black box warnings and withdrawals for prescription medications
KE Lasser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Clinical toxicological aspects of fluoroquinolones
R Stahlmann
TOXICOLOGY LETTERS (2002)
Underlying endotoxemia augments toxic responses to chlorpromazine: Is there a relationship to drug idiosyncrasy?
JP Buchweitz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Trovafloxacin hepatotoxicity
DA Lazarczyk et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission
K Kassahun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Immunological principles of adverse drug reactions - The initiation and propagation of immune responses elicited by drug treatment
DJ Naisbitt et al.
DRUG SAFETY (2000)
Acute eosinophilic hepatitis from trovafloxacin.
HJL Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Trovafloxacin-induced acute hepatitis
MI Lucena et al.
CLINICAL INFECTIOUS DISEASES (2000)
Troglitazone-induced fulminant hepatic failure
EJ Murphy et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Autoimmune hepatitis
P Obermayer-Straub et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
